Christina Applegate Explores Link Between Breast Implants and Pain

Christina Applegate, 54, has stated that she is looking into the possibility that her breast implants may be contributing to her ongoing pain and fatigue, particularly after discovering she had been misdiagnosed with multiple sclerosis (MS) in 2021.

During the November 10 episode of MeSsy, the podcast she co-hosts with Jamie-Lynn Sigler, Applegate, known for her role as a teenager in the popular sitcom Married With Children, mentioned that she had received a study indicating that symptoms associated with breast implants can mimic those of MS.

“Over the past five years, I’ve often wondered, ‘What if they’re leaking and causing me harm?'” she remarked, expressing her intention to discuss this with her healthcare providers.

In 2008, Applegate underwent a double mastectomy and breast reconstruction after being diagnosed with early-stage breast cancer and identifying a BRCA1 gene mutation, which elevates the risk of breast and other types of cancer. She mentioned on her podcast that she is “well overdue” for a replacement of her implants.

She has also reported experiencing increased pain and challenges in moving her right shoulder, stating that it can take her at least 10 minutes to sit up and rise from bed. She described these symptoms as overwhelming, noting that “there are so many different factors that could be at play.”

This inquiry follows a recent announcement from her doctors in October confirming that she does not have MS. At that time, Applegate shared that the news left her feeling as if she was back at “Square 1,” with her physical challenges persisting as she undergoes testing for other possible causes, including rheumatoid arthritis, lupus, and Lyme disease.

While the origins of Applegate’s symptoms remain unclear, there have been associations made between breast implants and certain illnesses in some instances, although the nature of these conditions is not fully understood.

Understanding Breast Implant Illness

As connections between breast implants and autoimmune diseases become clearer, women with breast implant illness urge doctors to warn others of the risks. Unknown hands hold a Biocell textured breast implant by Allergan.

Breast implant illness, or BII, refers to symptoms reported by some individuals with implants, including fatigue, cognitive changes, joint pain, and muscle pain. This image shows a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)

Breast implant illness, often referred to as BII, describes a range of symptoms reported by certain individuals with implants.

As of December 31, 2025, Health Canada had documented 663 reports of symptoms or diseases linked to breast implants, equating to roughly one report for every 1,025 implants sold in Canada.

Fatigue emerged as the most commonly reported symptom, followed by mood alterations, gastrointestinal issues, and cognitive changes. It is important to note that these are reports and not verified cases; Health Canada indicates that the available data cannot determine if implants caused these symptoms, which might stem from other origins.

The U.S. Food and Drug Administration (FDA) states that BII is not recognized as a formal medical diagnosis and lacks a specific diagnostic test. Reports of symptoms like fatigue and joint pain do not clarify how frequently they occur or their potential link to implants.

Julie Elliott, a patient advocate, licensed practical nurse (LPN), and Canadian representative for the Breast Implant Safety Alliance (BISA), who believes she was diagnosed with autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) due to her breast implants, informed CBC News that several symptoms reported by patients with implants can overlap with those of MS.

“Chronic fatigue, memory changes, trouble concentrating, numbness, tingling, nerve pain, muscle weakness, and hair loss — these are all symptoms that can be similar to those of MS,” Elliott stated.

However, she cautioned against assuming that Applegate’s implants are the cause of her symptoms. “I am not suggesting that Christina Applegate’s breast implants are responsible for her issues,” she noted, emphasizing that it would be “premature and irresponsible” to make such an assumption.

“Just because symptoms are similar does not mean the diagnosis is the same,” Elliott explained. “No potential cause should be dismissed or overlooked without thorough medical investigation.”

A woman in a large black dress and carrying a black cane, poses on a red carpet.

Christina Applegate, left, attends the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)

Dr. Stephen Nicolaidis, a plastic surgeon in Montreal who has treated over 1,500 patients for implant removal, stressed the importance of investigating other potential causes.

He characterized BII as a “diagnosis of exclusion,” which requires comprehensive evaluation of patients, and if no other causes are identified, the possibility that implants may be contributing to the issues should be considered.

Nicolaidis mentioned that common complaints include fatigue, hair loss, skin rashes, breathing difficulties, joint and muscle pain, sleep disturbances, and cognitive fog. Some of these symptoms may overlap with those associated with autoimmune disorders.

Reflecting on the symptoms described by Applegate, he remarked, “The issues she is experiencing can indeed be linked to her breast implants.” Nevertheless, the exact cause of BII remains unclear, and researchers have not yet provided definitive insights into how implants might contribute to these symptoms.

There is no specific test available to diagnose BII, according to Nicolaidis. While imaging may reveal silicone outside of an implant, he noted that such a finding is not a requirement for individuals to report symptoms. He also emphasized that BII should not be confused with implant-associated lymphoma, a type of cancer connected to certain textured implants.

Rupture, Removal, and Future Considerations

A rupture or leak presents a different issue from BII. The FDA lists rupture and deflation as potential complications of implants and recommends that patients report any new or unusual changes in their breasts to a healthcare professional.

Similarly, Health Canada advises individuals with implants to regularly monitor for any unusual breast changes and to talk to their doctor about any signs or symptoms. Decisions regarding the retention, replacement, or removal of implants should be made collaboratively with a clinician, taking into account individual symptoms, potential causes, and surgical risks.

They do not recommend preventative implant removal due to the inherent risks of surgery, and advise anyone experiencing symptoms to consult a healthcare provider.

Nicolaidis advised individuals experiencing symptoms to seek a comprehensive medical assessment. If no other potential causes are identified, they can discuss the possibility that implants might be a contributing factor and explore options with their healthcare providers.

He ceased placing breast implants in 2021, concluding that the risks often outweigh the benefits, and has since focused on implant removal. He cautioned that removal does not guarantee a cure; some patients with MS have reported only minimal improvement, and individuals with diagnosed autoimmune diseases may still require medical treatment following explant surgery.

Elliott believes that symptoms related to implants warrant serious consideration, while acknowledging that their underlying causes are not entirely understood. She encourages patients to seek well-rounded, evidence-based information and to track any changes in their health.

“The absence of complete answers does not mean we should dismiss women’s experiences,” she remarked.